… involved during ischemic stroke are … of the ischemic core. This review will discuss the
molecular aspects of oxidative stress and inflammation in ischemic stroke and potential therapeutic …

… Stroke contributes significantly to death, disability, and healthcare costs; however, …
thrombolytic therapy for acute ischemic stroke. One area of development for new ischemic stroke …

… So in a final wrap, we can say that ischemic stroke is a fatal condition and researchers
got success to handle this up to a certain extent only. Some significant treatments such as …

… Gene therapy, stem cell therapy and neurological grafts for stroke are still in … therapies into
human clinical stroke trials. A more immediate clinical application of genetics to stroke therapy …

… approaches explored by researchers in recent years for improved treatment of ischemic
stroke. … also being investigated in stroke therapy, which could impact ischemic stroke outcome. …

… GDNF could be one of the promising candidates for therapy of acute cerebrovascular injury,
… On those limitations, the gene therapy approach has great advantages in that an amount of …

… limits rt-PA treatment to a small percentage of ischemic stroke patients [20]. Although
neuroprotective therapies, and other approaches including erythropoietin, N-methyl d-aspartate …

… studies with neuroprotective medicines, the hunt for alternative therapeutic approaches has
become even more critical for patients recovering from ischemic stroke (Xiong et al. 2022). In …

One of the most important causes of neurological morbidity and mortality in the world is
ischemic stroke. It can be a result of multiple events such as embolism with a cardiac origin, …

… Ischemic stroke accounts for over 80% of all strokes and is one of the leading causes of … )
is an approved treatment strategy for acute ischemic stroke of large arteries within 4.5 h of onset…